Please check your internet connection and try again.
# Folic Acid
## Overview
Folic acid (Vitamin B9) is a water-soluble B vitamin essential for DNA synthesis, repair, and erythropoiesis. It is a synthetic form of folate used as a supplement or therapeutic agent for deficiency states and the prevention of neural tube defects.
## Primary Indications
* Treatment of folate deficiency megaloblastic anemia.
* Prevention of neural tube defects (NTDs) in pregnancy.
* Prophylaxis in chronic hemolytic anemia or renal dialysis.
* Reduction of side effects associated with methotrexate therapy.
## Adult Dosing
* **Deficiency Treatment:** 1 mg daily. Higher doses (up to 5 mg/day) may be required for malabsorption syndromes.
* **Pregnancy (NTD Prevention):** 400 mcg (0.4 mg) to 800 mcg (0.8 mg) daily. High-risk patients (previous NTD pregnancy) may require 4 mg daily.
* **Methotrexate Supplementation:** 1 mg daily or 5 mg weekly (non-methotrexate day), per local protocol or prescriber preference.
## Pediatric Dosing
* **Deficiency Treatment:** 0.5 to 1 mg daily for infants and children; neonates may require 0.1 mg daily.
* **Maintenance:** 0.1 mg daily for infants; 0.3 mg daily for children 1–3 years; 0.4 mg daily for children 4+ years.
* *Note: Dosing often follows specific institutional protocols based on underlying pathology.*
## Dose Adjustments
* **Renal Impairment:** No specific adjustment required; however, patients on dialysis require supplementation due to clearance during the procedure.
* **Hepatic Impairment:** No standard adjustment required.
## Contraindications
* Hypersensitivity to folic acid.
* **Warning:** Do not use as monotherapy in Vitamin B12 deficiency (pernicious anemia) as it may mask neurological progression while improving hematologic markers.
## Adverse Effects
* Generally well-tolerated.
* Rare: Allergic reactions (rash, pruritus, bronchospasm), gastrointestinal distress (nausea, abdominal bloating), or altered sleep patterns/irritability with very high doses.
## Key Drug Interactions
* **Methotrexate:** Folic acid may decrease the efficacy of methotrexate in cancer treatment.
* **Anticonvulsants (e.g., Phenytoin, Phenobarbital, Primidone):** Folic acid can decrease serum levels of these medications, potentially reducing seizure control.
* **Sulfonamides/Trimethoprim:** May interfere with folate metabolism.
## Monitoring
* Monitor hemoglobin/hematocrit and reticulocyte counts to evaluate efficacy in anemia treatment.
* Monitor serum B12 levels if high-dose folic acid is used to ensure underlying B12 deficiency is not masked.
## Clinical Pearls
* **Masking Effect:** Always rule out Vitamin B12 deficiency before initiating high-dose folic acid supplementation in patients with megaloblastic anemia.
* **Stability:** Highly sensitive to light and heat; keep in a tightly closed, light-resistant container.
* **Food Intake:** Bioavailability is high and it can be taken regardless of meals.
***
*Disclaimer: This information is for educational purposes only. Always verify current prescribing information, institutional protocols, and patient-specific factors via reliable clinical resources (e.g., Lexicomp, Micromedex) before prescribing or administering medication.*